69
Views
7
CrossRef citations to date
0
Altmetric
Scientific Article

Pharmacokinetics of levamisole in sheep after intravenous administration

, , , &
Pages 63-66 | Accepted 27 Dec 1996, Published online: 22 Feb 2011
 

Abstract

The pharmacokinetics of levamisole at doses of 5, 7.5 and 10 mg/kg were determined after its intravenous administration to eighteen healthy Merino sheep. Using compartmental analysis, the disposition of the drug best fitted a two-compartmental open model. The mean values for the compartmental volume of distribution at steady state (Vss) were 2.034 ± 0.23I, 2.347 ± 0.720 and 2.001 ± 0.367 I/kg for each dose, respectively, and values obtained using the statistical moment theory were 2.141 ± 0.269, 2.390 ± 0.536 and 2.140 ± 0.345 l/kg for each dose, respectively. There were no dose-related differences (one-way ANOVA) in the constants describing distribution and elimination phases (α and β) or Vss, but significant differences were detected in the total body clearance (Cl) and the area under the plasma concentration-time curve (AUC). After non-compartmental analysis, no significant differences were found when the parameters λ (the linear terminal slope) and Vss were compared, but significant differences were detected in Cl and AUC. There were no significant differences between the values obtained using the compartmental and non- compartmental analysis when λ-β, Cl, Vss and AUC were compared.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.